Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,904 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review.
Nishimura K, Ishikawa T, Okamoto N, Akamine K, Inoue N, Irabu H, Kato K, Keino H, Kojima M, Kubo H, Maruyama K, Mizuta M, Shabana K, Shimizu M, Sugita Y, Takakuwa Y, Takanashi S, Takase H, Umebayashi H, Umezawa N, Yamanishi S, Yamazaki K, Yashiro M, Yasumi T, Mori M. Nishimura K, et al. Among authors: maruyama k. Mod Rheumatol. 2024 Dec 25;35(1):167-173. doi: 10.1093/mr/roae046. Mod Rheumatol. 2024. PMID: 38753302
Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study.
Takeuchi M, Usui Y, Namba K, Keino H, Takeuchi M, Takase H, Kamoi K, Hase K, Ito T, Nakai K, Maruyama K, Kobayashi E, Mashimo H, Sato T, Ohguro N, Hori J, Okada AA, Sonoda KH, Mizuki N, Goto H. Takeuchi M, et al. Among authors: maruyama k. Front Med (Lausanne). 2023 Jan 20;10:1095423. doi: 10.3389/fmed.2023.1095423. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744150 Free PMC article.
Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review.
Ishikawa T, Nishimura K, Okamoto N, Akamine K, Inoue N, Irabu H, Kato K, Keino H, Kojima M, Kubo H, Maruyama K, Mizuta M, Shabana K, Shimizu M, Sugita Y, Takakuwa Y, Takanashi S, Takase H, Umebayashi H, Umezawa N, Yamanishi S, Yamazaki K, Yashiro M, Yasumi T, Mori M. Ishikawa T, et al. Among authors: maruyama k. Mod Rheumatol. 2024 Dec 25;35(1):174-184. doi: 10.1093/mr/roae050. Mod Rheumatol. 2024. PMID: 38795057
Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan.
Soma T, Oie Y, Takayanagi H, Matsubara S, Yamada T, Nomura M, Yoshinaga Y, Maruyama K, Watanabe A, Takashima K, Mao Z, Quantock AJ, Hayashi R, Nishida K. Soma T, et al. Among authors: maruyama k. Lancet. 2024 Nov 16;404(10466):1929-1939. doi: 10.1016/S0140-6736(24)01764-1. Epub 2024 Nov 7. Lancet. 2024. PMID: 39522528 Free PMC article.
Neurosyphilis concurrently involving eye and ear.
Nakagami F, Hagiya H, Maruyama K, Onishi Y. Nakagami F, et al. Among authors: maruyama k. BMJ Case Rep. 2018 Oct 21;2018:bcr2018227185. doi: 10.1136/bcr-2018-227185. BMJ Case Rep. 2018. PMID: 30344157 Free PMC article. No abstract available.
Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma.
Komatsu H, Usui Y, Tsubota K, Fujii R, Yamaguchi T, Maruyama K, Wakita R, Asakage M, Hamada K, Yamakawa N, Nezu N, Ueda K, Goto H. Komatsu H, et al. Among authors: maruyama k. Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):2. doi: 10.1167/iovs.64.15.2. Invest Ophthalmol Vis Sci. 2023. PMID: 38038618 Free PMC article.
2,904 results